Investors sold shares of Cognex Co. (NASDAQ:CGNX) on strength during trading on Monday. $10.13 million flowed into the stock on the tick-up and $30.20 million flowed out of the stock on the tick-down, for a money net flow of $20.07 million out of the stock. Of all equities tracked, Cognex had the 0th highest net out-flow for the day. Cognex traded up $0.83 for the day and closed at $58.96

Several research firms have commented on CGNX. BidaskClub raised shares of Cognex from a “hold” rating to a “buy” rating in a research report on Wednesday. Northcoast Research cut shares of Cognex from a “buy” rating to a “neutral” rating and set a $54.00 target price on the stock. in a research report on Friday, August 24th. They noted that the move was a valuation call. Zacks Investment Research cut shares of Cognex from a “hold” rating to a “sell” rating in a research report on Thursday, July 26th. Robert W. Baird reissued a “hold” rating and set a $48.00 target price on shares of Cognex in a research report on Tuesday, July 31st. Finally, ValuEngine raised shares of Cognex from a “strong sell” rating to a “sell” rating in a research report on Friday, June 1st. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and four have given a buy rating to the company’s stock. Cognex presently has a consensus rating of “Hold” and an average price target of $54.79.

The company has a market capitalization of $10.14 billion, a PE ratio of 42.11 and a beta of 1.66.

Cognex (NASDAQ:CGNX) last issued its quarterly earnings results on Monday, July 30th. The scientific and technical instruments company reported $0.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.02. Cognex had a net margin of 20.57% and a return on equity of 22.95%. The company had revenue of $211.26 million during the quarter, compared to analyst estimates of $204.87 million. During the same quarter last year, the business posted $0.63 EPS. Cognex’s quarterly revenue was up 18.6% compared to the same quarter last year. research analysts predict that Cognex Co. will post 1.19 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, August 31st. Stockholders of record on Friday, August 17th were paid a dividend of $0.045 per share. The ex-dividend date was Thursday, August 16th. This represents a $0.18 annualized dividend and a dividend yield of 0.31%. Cognex’s payout ratio is currently 12.41%.

In other news, Director Anthony Sun sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, August 6th. The shares were sold at an average price of $53.01, for a total transaction of $530,100.00. Following the completion of the sale, the director now owns 284,262 shares in the company, valued at approximately $15,068,728.62. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jerry A. Schneider sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 11th. The stock was sold at an average price of $54.29, for a total transaction of $271,450.00. Following the sale, the director now owns 7,000 shares of the company’s stock, valued at approximately $380,030. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 27,500 shares of company stock valued at $1,493,200. 5.40% of the stock is currently owned by company insiders.

Several hedge funds have recently modified their holdings of the company. Northern Trust Corp increased its stake in shares of Cognex by 1.4% during the 2nd quarter. Northern Trust Corp now owns 1,470,270 shares of the scientific and technical instruments company’s stock worth $65,589,000 after purchasing an additional 20,525 shares during the last quarter. Sturgeon Ventures LLP increased its stake in shares of Cognex by 14.1% during the 2nd quarter. Sturgeon Ventures LLP now owns 139,605 shares of the scientific and technical instruments company’s stock worth $6,250,000 after purchasing an additional 17,205 shares during the last quarter. Bank of New York Mellon Corp grew its stake in Cognex by 15.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,260,702 shares of the scientific and technical instruments company’s stock valued at $368,509,000 after buying an additional 1,124,420 shares in the last quarter. Schroder Investment Management Group grew its stake in Cognex by 26.5% in the 2nd quarter. Schroder Investment Management Group now owns 335,873 shares of the scientific and technical instruments company’s stock valued at $14,789,000 after buying an additional 70,380 shares in the last quarter. Finally, Advisors Asset Management Inc. grew its stake in Cognex by 12.0% in the 2nd quarter. Advisors Asset Management Inc. now owns 26,902 shares of the scientific and technical instruments company’s stock valued at $1,200,000 after buying an additional 2,886 shares in the last quarter. Institutional investors own 90.28% of the company’s stock.

About Cognex (NASDAQ:CGNX)

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. The company offers machine vision products, which are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Recommended Story: How to Invest in an Index Fund

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.